Fetal-tissue transplants in Parkinson's disease

S Fahn

Clinical Trial

S Fahn. N Engl J Med. 1992.

. 1992 Nov 26;327(22):1589-90.

doi: 10.1056/NEJM199211263272209.

S Fahn

No abstract available

Comment on

Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease.
Spencer DD, Robbins RJ, Naftolin F, Marek KL, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, et al. Spencer DD, et al. N Engl J Med. 1992 Nov 26;327(22):1541-8. doi: 10.1056/NEJM199211263272201. N Engl J Med. 1992. PMID: 1435880 Clinical Trial.
Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease.
Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Kriek E, Qi JX, Lone T, Zhang YB, Snyder JA, Wells TH, et al. Freed CR, et al. N Engl J Med. 1992 Nov 26;327(22):1549-55. doi: 10.1056/NEJM199211263272202. N Engl J Med. 1992. PMID: 1435881 Clinical Trial.
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O, Langston JW. Widner H, et al. N Engl J Med. 1992 Nov 26;327(22):1556-63. doi: 10.1056/NEJM199211263272203. N Engl J Med. 1992. PMID: 1435882 Clinical Trial.